Galenus Rx is thrilled to announce that Larry Lesko, the Chair of our newly formed Scientific Advisory Board and a longtime advisor, has been recognized for co-authoring one of the Top Downloaded Articles in the prestigious journal “Clinical and Translational Science” by the American Society for Clinical Pharmacology and Therapeutics.
The article, “A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development,” ranks among the top 10% most-read papers published by the journal in 2022.
We are immensely proud to benefit from Larry’s expertise and are excited to see the significant impact his important work continues to make in the field of clinical pharmacology and therapeutics.
